Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects

"Cohort 1: RDEA3170 2.5 mg, 7.5 mg (2.5 mg × 3 tablets), and 15 mg (2.5 mg × 6 tablets).~Cohort 2: RDEA3170 5 mg (2.5 mg × 2 tablets), 10 mg (2.5 mg × 4 tablets), and 20 mg (2.5 mg × 8 tablets)."

allopurinol 300 mg, allopurinol 600 mg (300 mg x 2 tablets)